These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 14689377

  • 1. HTLV-I/II prevalence in different geographic locations.
    Vrielink H, Reesink HW.
    Transfus Med Rev; 2004 Jan; 18(1):46-57. PubMed ID: 14689377
    [Abstract] [Full Text] [Related]

  • 2. Human T-lymphotropic virus type II and neurological disease.
    Araujo A, Hall WW.
    Ann Neurol; 2004 Jul; 56(1):10-9. PubMed ID: 15236397
    [Abstract] [Full Text] [Related]

  • 3. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires].
    Blejer JL, Saguier MC, Salamone HJ, Carreras LA.
    Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226
    [Abstract] [Full Text] [Related]

  • 4. The epidemiology and disease outcomes of human T-lymphotropic virus type II.
    Roucoux DF, Murphy EL.
    AIDS Rev; 2004 Dec; 6(3):144-54. PubMed ID: 15595431
    [Abstract] [Full Text] [Related]

  • 5. The prevalence of human T-lymphotropic virus infection among blood donors in southeast China, 2004-2013.
    Xie J, Ge S, Zhang Y, Lin Y, Ni H, Zhang J, Chen C.
    PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003685. PubMed ID: 25830656
    [Abstract] [Full Text] [Related]

  • 6. [Investigation of anti-HTLV I/II seroprevalence in healthy blood donors in Izmir region, Turkey].
    Sertöz R, Turhan A, Bozkurt H, Samlıoğlu P, Değirmenci A, Aydınok Y, Erensoy S.
    Mikrobiyol Bul; 2010 Oct; 44(4):579-84. PubMed ID: 21063970
    [Abstract] [Full Text] [Related]

  • 7. [Clinical and biological epidemiology of onco-retroviral HTLV-I and II infections].
    De Thé G.
    Bull Acad Natl Med; 1991 Oct; 175(6):861-9; discussion 869-70. PubMed ID: 1742624
    [Abstract] [Full Text] [Related]

  • 8. [Seroprevalence of HTLV-1/2 in blood donors from Misiones Province].
    Malan R, Berini CA, Eirin ME, Delfino CM, Pedrozo W, Krupp R, García Plichta A, Biglione MM.
    Medicina (B Aires); 2010 Oct; 70(1):71-4. PubMed ID: 20228028
    [Abstract] [Full Text] [Related]

  • 9. Seroepidemiology of HTLV-I/II in Argentina: an overview.
    Gastaldello R, Hall WW, Gallego S.
    J Acquir Immune Defic Syndr; 2004 Mar 01; 35(3):301-8. PubMed ID: 15076246
    [Abstract] [Full Text] [Related]

  • 10. [Human T-lymphotropic virus I/II detection in Chilean patients from Sexually Transmitted Diseases clinics].
    Sanhueza D, Ramírez E, Navarrete N, Santander E, Garmendia ML, Martínez MJ.
    Rev Med Chil; 2012 Oct 01; 140(10):1239-44. PubMed ID: 23559279
    [Abstract] [Full Text] [Related]

  • 11. [Human T-lymphotrophic virus type I and II--diagnosis and clinical presentation].
    Christiansen CB.
    Ugeskr Laeger; 1994 Dec 19; 156(51):7663-7. PubMed ID: 7839528
    [Abstract] [Full Text] [Related]

  • 12. Human T cell lymphotropic viruses (HTLV-I/II) in South America: should it be a public health concern?
    Carneiro-Proietti AB, Catalan-Soares B, Proietti FA, GIPH (Interdisciplinary HTLV-1/II Research Group).
    J Biomed Sci; 2002 Dec 19; 9(6 Pt 2):587-95. PubMed ID: 12432224
    [Abstract] [Full Text] [Related]

  • 13. Human retroviruses.
    Weber T, Hunsmann G, Stevens W, Fleming AF.
    Baillieres Clin Haematol; 1992 Apr 19; 5(2):273-314. PubMed ID: 1324749
    [Abstract] [Full Text] [Related]

  • 14. Relation between human T-lymphotropic virus type I and neurologic diseases in Panama: 1985-1990.
    Gracia F, Castillo LC, Larreategui M, Roberts B, Cedeño V, Heneine W, Blattner W, Kaplan JE, Levine PH.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Oct 01; 10(2):192-7. PubMed ID: 7552485
    [Abstract] [Full Text] [Related]

  • 15. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
    Gessain A, Mahieux R.
    Rev Neurol (Paris); 2012 Mar 01; 168(3):257-69. PubMed ID: 22405461
    [Abstract] [Full Text] [Related]

  • 16. The prevalence of human T-lymphotropic virus type 1 & 2 (HTLV-1/2) in South African blood donors.
    Vermeulen M, Sykes W, Coleman C, Custer B, Jacobs G, Jaza J, Kaidarova Z, Hlela C, Gessain A, Cassar O, Poole C, Ingram C, Murphy EL, Reddy R.
    Vox Sang; 2019 Jul 01; 114(5):451-458. PubMed ID: 30950074
    [Abstract] [Full Text] [Related]

  • 17. Vertical transmission of HTLV-I/II: a review.
    Bittencourt AL.
    Rev Inst Med Trop Sao Paulo; 1998 Jul 01; 40(4):245-51. PubMed ID: 9876439
    [Abstract] [Full Text] [Related]

  • 18. Global epidemiology of HTLV-I infection and associated diseases.
    Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL.
    Oncogene; 2005 Sep 05; 24(39):6058-68. PubMed ID: 16155612
    [Abstract] [Full Text] [Related]

  • 19. Tropical spastic paraparesis/HTLV-I-associated myelopathy in Europe and in Africa: clinical and epidemiologic aspects.
    Touzé E, Gessain A, Lyon-Caen O, Gout O.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Sep 05; 13 Suppl 1():S38-45. PubMed ID: 8797702
    [Abstract] [Full Text] [Related]

  • 20. HTLV in the Americas: challenges and perspectives.
    Carneiro-Proietti AB, Catalan-Soares BC, Castro-Costa CM, Murphy EL, Sabino EC, Hisada M, Galvão-Castro B, Alcantara LC, Remondegui C, Verdonck K, Proietti FA.
    Rev Panam Salud Publica; 2006 Jan 05; 19(1):44-53. PubMed ID: 16536938
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.